CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY
|
0.600 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
De Novo Missense Variants in TRAF7 Cause Developmental Delay, Congenital Anomalies, and Dysmorphic Features.
|
29961569 |
2018 |
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY
|
0.600 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
De Novo Missense Variants in TRAF7 Cause Developmental Delay, Congenital Anomalies, and Dysmorphic Features.
|
29961569 |
2018 |
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY
|
0.600 |
GeneticVariation
|
disease |
UNIPROT |
De Novo Missense Variants in TRAF7 Cause Developmental Delay, Congenital Anomalies, and Dysmorphic Features.
|
29961569 |
2018 |
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY
|
0.600 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Excess of rare, inherited truncating mutations in autism.
|
25961944 |
2015 |
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY
|
0.600 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Excess of rare, inherited truncating mutations in autism.
|
25961944 |
2015 |
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY
|
0.600 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY
|
0.600 |
GeneticVariation
|
disease |
CLINVAR |
|
|
|
Global developmental delay
|
0.410 |
GeneticVariation
|
disease |
BEFREE |
De Novo Missense Variants in TRAF7 Cause Developmental Delay, Congenital Anomalies, and Dysmorphic Features.
|
29961569 |
2018 |
Global developmental delay
|
0.410 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Excess of rare, inherited truncating mutations in autism.
|
25961944 |
2015 |
Global developmental delay
|
0.410 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Excess of rare, inherited truncating mutations in autism.
|
25961944 |
2015 |
Global developmental delay
|
0.410 |
Biomarker
|
disease |
HPO |
|
|
|
Global developmental delay
|
0.410 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Meningioma
|
0.390 |
GeneticVariation
|
disease |
BEFREE |
Specifically, TRAF7 mutations could play a key role in skull base meningiomas by regulating the expression of inhibitory immune checkpoints and thus suppressing immune responses.
|
31177425 |
2019 |
Meningioma
|
0.390 |
GeneticVariation
|
disease |
BEFREE |
Characteristic AKT/SMO, KLF4/TRAF7 and pTERT genetic alterations seen in adults are distinctly absent in pediatric meningiomas.
|
28901666 |
2018 |
Meningioma
|
0.390 |
GeneticVariation
|
disease |
BEFREE |
We found a higher frequency of PIK3CA mutations [14/40 (35%) versus 18/530 (3%), P < 10-8] and TRAF7 mutations [16/40 (40%) versus 140/530 (26%), P < 0.001] and a lower frequency of NF2-related tumors compared with the control population of meningiomas [3/40 (7.5%) versus 169/530 (32%), P < 0.001].
|
29206892 |
2018 |
Meningioma
|
0.390 |
GeneticVariation
|
disease |
BEFREE |
The importance of NF2 (neurofibromin 2), TRAF7 (tumor necrosis factor [TNF] receptor-associated factor 7), KLF4 (Kruppel-like factor 4), AKT1, SMO (smoothened), PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), and POLR2 (RNA polymerase II subunit A) demonstrates that there are at least 6 distinct mutational classes of meningiomas.
|
29852774 |
2018 |
Meningioma
|
0.390 |
GeneticVariation
|
disease |
BEFREE |
In addition, these cell lines also harbored known meningioma driver mutations in neurofibromin 2 (NF2) and TNF receptor-associated factor 7 (TRAF7).
|
28552950 |
2017 |
Meningioma
|
0.390 |
GeneticVariation
|
disease |
BEFREE |
Ten of 16 (60%) tumor cases had mutations in the WD40 domain of TRAF7, the same location for causal mutations of meningiomas.
|
28019650 |
2017 |
Meningioma
|
0.390 |
Biomarker
|
disease |
BEFREE |
After targeted sequencing of known mutated genes in meningiomas, we discovered TRAF7 mutations in two out of four tumors, stressing the importance of focusing the research efforts of the meningioma community in understanding the mechanisms underlying TRAF7 related meningioma tumorigenesis.
|
28536991 |
2017 |
Meningioma
|
0.390 |
GeneticVariation
|
disease |
BEFREE |
We report genomic analysis of 300 meningiomas, the most common primary brain tumors, leading to the discovery of mutations in TRAF7, a proapoptotic E3 ubiquitin ligase, in nearly one-fourth of all meningiomas.
|
23348505 |
2013 |
Meningioma
|
0.390 |
GeneticVariation
|
disease |
BEFREE |
In conclusion, our findings suggest an essential contribution of combined KLF4 K409Q and TRAF7 mutations in the genesis of secretory meningioma and demonstrate a role for TRAF7 alterations in other non-NF2 meningiomas.
|
23404370 |
2013 |
Meningioma
|
0.390 |
CausalMutation
|
disease |
CGI |
|
|
|
Malignant mesothelioma
|
0.310 |
GeneticVariation
|
disease |
BEFREE |
Together, these studies demonstrate that well-differentiated papillary mesothelioma is genetically defined by mutually exclusive mutations in TRAF7 and CDC42 that molecularly distinguish this entity from malignant mesothelioma.
|
30171198 |
2019 |
Malignant mesothelioma
|
0.310 |
Biomarker
|
disease |
CTD_human |
Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations.
|
26928227 |
2016 |
Congenital Heart Defects
|
0.300 |
Biomarker
|
group |
GENOMICS_ENGLAND |
Excess of rare, inherited truncating mutations in autism.
|
25961944 |
2015 |